SAB Biotherapeutics, Inc. (SABS): 10-Q filed Aug 6, 2026

Form type
10-Q
Filing date
Aug 6, 2026
Accession number
0001193125-26-336783
Filer
SAB Biotherapeutics, Inc. (CIK 1833214)